Novo Nordisk is gearing up to submit its rare blood disorder drug to the FDA after the former Forma Therapeutics asset reduced a painful complication of sickle cell disease (SCD) in a phase 3 study.
The water restrictions taking effect Monday in Raleigh are expected to last more than a month, according to a city spokesperson. City of Raleigh environmental coordinator Ed Buchan estimated that the ...
Not too long ago I would have said I was one of the least likely people to be tempted by GLP-1s like Wegovy or Zepbound. My weight has always been average. I have no medical conditions, and more than ...
Denver Board of Water Commissioners adopted a resolution approving the implementation of temporary drought pricing at a meeting Wednesday. Denver Water said that the drought pricing will apply ...
The World Anti-Doping Agency (WADA) said it is now monitoring GLP-1 use among elite athletes, including at the Winter Olympics in Italy. Being ‘monitored’ does not mean a substance is prohibited; ...
A box blade can handle leveling, grading, and cleanup jobs that make it one of the most useful first tools to own. It is the kind of implement that quickly proves its value the moment real work starts ...
Corebridge Financial and Equitable Holdings have agreed to an all-stock merger valued at approximately $22 billion that will create a life insurance, annuity, wealth and asset management company ...
For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...
Washington state has beaten California and New York in their race to soak the rich. While California and New York have, respectively, the highest and third-highest state income tax rates, Washington's ...
Brianna "Chickenfry" LaPaglia is slamming the use of Ozempic for weight loss. The reality TV star and Barstool Sports personality, 26, got candid about the growing use of GLP-1 weight loss medications ...
Although one GLP-1 study made national headlines about the drug class’ potential use in addiction treatment, other research indicates GLP-1s could increase the risk of bone injuries and are less ...
For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 drugs are not yet an approved addiction treatment. But the evidence base is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results